| Original language | English (Ireland) |
|---|---|
| Media of output | Abstract |
| Volume | 126 |
| Publication status | Published - 1 Dec 2015 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Results from the International, Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Patients 65 Years and Older with Treatment-Naive CLL SLL (RESONATE-2 (TM))
- Michael O'Dwyer
Research output: Other contribution (Published) › Other contribution